In this session, you will receive the most important cardiology updates from 2018-2019, including trial evidence for dietary supplements in the prevention of cardiovascular disease and new information about the blood cholesterol guidelines. The session will also provide advice on how to differentiate between opportunistic and systematic screening for atrial fibrillation as well as identify ways to conduct this screening in practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 8th 2020 and they are subject to change as new information is published.
This presentation will provide an updated on newer approaches to the management of lipid disorders for the primary and secondary prevention of atherosclerotic cardiovascular disease and hypertriglyceridemia-induced acute pancreatitis. It will also provide an evidence-based approach to the management of lipid disorders in special populations. The focus will be on the recommendations provided by the 2018 ACC/AHA Guidelines on the Treatment of Blood Cholesterol and the application of these clinical guidelines in patient care.
Expert faculty discuss how to optimize the use of PCSK9 inhibitors in the management of individuals with coronary heart disease.
Obesity, dyslipidemia, and hypertension are significant challenges to public health and impact a growing number of Americans. Weight loss and dietary changes are effective in preventing CVD and DMII and reducing cardiometabolic complications, but can be difficult for many people. Growing evidence supports the use of timed fasting to promote weight loss and reduce these complications. Join us as we discuss a recent study that shows promising data regarding a 10-hour feeding window and improved CV markers.
Managing cholesterol is one of the most common clinical problems. Recently, the American College of Cardiology and the American Heart Association issued new guidance on the management of blood cholesterol. Ten other societies participated in the development of the guidelines. Listen to find out who should be treated with statins, what the treatment targets are, and when other cholesterol-lowering medications should be added.